3D printing of pharmaceuticals. ([2018])
- Record Type:
- Book
- Title:
- 3D printing of pharmaceuticals. ([2018])
- Main Title:
- 3D printing of pharmaceuticals
- Further Information:
- Note: Abdul W. Basit, Simon Gaisford, editors.
- Editors:
- Basit, Abdul W
Gaisford, Simon - Contents:
- Intro; Preface; Contents; Contributors; About the Editors; Chapter 1: The Shape of Things to Come: Emerging Applications of 3D Printing in Healthcare; 1 3D Printing: The Next Industrial Revolution; 1.1 3D Printing in Medicine: An Overview; 2 Personalised Medicines; 2.1 Dose Personalisation; 2.2 Multi-drug Combinations; 2.3 Tailored Release Profiles; 2.4 Improved Patient Acceptability; 2.5 On-demand Printing; 3 Early Phase Drug Development; 3.1 Pre-clinical Studies and FIH Trials; 3.2 Motivations for Using 3DP in Early Phase Drug Development; 3.2.1 Dose Flexibility; 3.3 Immediate Manufacture 3.4 Reduced Resource Investment3.5 Unique Characteristics; 4 Conclusion; References; Chapter 2: 3D Printing Technologies, Implementation and Regulation: An Overview; 1 Introduction; 2 Classification of 3D Printing Technologies; 2.1 Industrial Applications of 3D Printing; 2.2 3D Printing Software; 2.3 Binder Jet Printing; 2.4 Vat Polymerisation; 2.4.1 Stereolithography; 2.5 Powder Bed Fusion; 2.5.1 Selective Laser Sintering; 2.6 Material Extrusion; 2.6.1 Fused Deposition Modelling; 2.6.2 Semisolid Extrusion; 2.6.3 Bioprinting; 2.7 Directed Energy Deposition; 2.8 Sheet Lamination 3 3D Printing Implementation in Healthcare3.1 Rapid Administration and Improved Medicine Access; 3.2 3D Printing and Wearable Diagnostics; 3.3 Challenges to 3D Printing Implementation; 4 Regulatory Requirements; 4.1 Regulatory Considerations of 3D Printing in Pharmaceutics; 5 Conclusion; References; Chapter 3:Intro; Preface; Contents; Contributors; About the Editors; Chapter 1: The Shape of Things to Come: Emerging Applications of 3D Printing in Healthcare; 1 3D Printing: The Next Industrial Revolution; 1.1 3D Printing in Medicine: An Overview; 2 Personalised Medicines; 2.1 Dose Personalisation; 2.2 Multi-drug Combinations; 2.3 Tailored Release Profiles; 2.4 Improved Patient Acceptability; 2.5 On-demand Printing; 3 Early Phase Drug Development; 3.1 Pre-clinical Studies and FIH Trials; 3.2 Motivations for Using 3DP in Early Phase Drug Development; 3.2.1 Dose Flexibility; 3.3 Immediate Manufacture 3.4 Reduced Resource Investment3.5 Unique Characteristics; 4 Conclusion; References; Chapter 2: 3D Printing Technologies, Implementation and Regulation: An Overview; 1 Introduction; 2 Classification of 3D Printing Technologies; 2.1 Industrial Applications of 3D Printing; 2.2 3D Printing Software; 2.3 Binder Jet Printing; 2.4 Vat Polymerisation; 2.4.1 Stereolithography; 2.5 Powder Bed Fusion; 2.5.1 Selective Laser Sintering; 2.6 Material Extrusion; 2.6.1 Fused Deposition Modelling; 2.6.2 Semisolid Extrusion; 2.6.3 Bioprinting; 2.7 Directed Energy Deposition; 2.8 Sheet Lamination 3 3D Printing Implementation in Healthcare3.1 Rapid Administration and Improved Medicine Access; 3.2 3D Printing and Wearable Diagnostics; 3.3 Challenges to 3D Printing Implementation; 4 Regulatory Requirements; 4.1 Regulatory Considerations of 3D Printing in Pharmaceutics; 5 Conclusion; References; Chapter 3: Binder Jet Printing in Pharmaceutical Manufacturing; 1 Introduction; 2 Binder Jet Methodology; 3 Pharmaceutical Applications of Binder Jet Printing; 3.1 Controlled-Release Formulations; 3.2 Rapidly Dissolving Tablets; 3.3 Spritam®: The First FDA Approved 3D printed Product 4 Benefits and Drawbacks5 Conclusion; References; Chapter 4: The History, Developments and Opportunities of Stereolithography; 1 Introduction; 1.1 History of stereolithography; 2 Stereolithography; 2.1 The Stereolithographic 3DP Process; 2.2 Photopolymerisation; 2.2.1 Light Sources; 2.2.2 Photoinitiators; 3 Materials and Biomedical uses of Sterolithography; 3.1 Biocompatibility; 4 Conclusion; References; Chapter 5: Powder Bed Fusion: The Working Process, Current Applications and Opportunities; 1 Historical Development; 2 The Working Process; 2.1 Printing Parameters 2.1.1 Powder Bed Temperature2.1.2 Types of Lasers; 2.1.3 Particle Size and Shape; 2.1.4 Layer Thickness; 2.1.5 Additional Parameters; 3 Classification; 3.1 Solid-State Sintering; 3.2 Liquid-Phase Sintering; 3.3 Partial Melting; 3.4 Liquid-State Melting; 4 Materials in PBF; 4.1 Thermoplastic Polymers; 4.2 Metals; 4.3 Ceramics; 5 Industrial Applications of PBF; 5.1 Medical Applications of PBF; 5.2 Metallic Devices; 5.3 Tissue Engineering; 5.4 PBF in Pharmaceutics; 6 Conclusion; References; Chapter 6: Fused Deposition Modelling: Advances in Engineering and Medicine; 1 Introduction … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2018
- Copyright Date:
- 2018
- Extent:
- 1 online resource
- Subjects:
- 338.4/76151
Medicine
Pharmaceutical industry -- Technological innovations
Three-dimensional printing
Pharmaceutical technology
Biomedical engineering
BUSINESS & ECONOMICS / Industries / General
Pharmaceutical industry -- Technological innovations
Three-dimensional printing
Medical -- Allied Health Services -- Medical Technology
Biomedical engineering
Medical -- Pharmacy
Pharmaceutical technology
Electronic books - Languages:
- German
- ISBNs:
- 9783319907550
3319907557 - Related ISBNs:
- 9783319907543
3319907549 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (EBSCO, viewed August 13, 2018). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.367677
- Ingest File:
- 02_346.xml